V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20215211 | 20155503 | 1.75 | 88.6 | Palliative (P) | null | 2020-11-29 | EOX | 1 | N | SORAFENIB | 100797482 |
| 20215214 | 20155504 | 1.68 | 90 | Palliative (P) | 2020-07-01 | 2020-07-17 | EOX | 02 | N | CAPECITABINE + RT | 100926598 |
| 20215216 | 20155505 | 1.58 | 56.8 | Palliative (P) | 2018-05-24 | 2018-05-24 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 100665266 |
| 20215217 | 20155506 | 1.69 | 76.9 | 03 | 2018-08-29 | 2018-08-31 | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101077415 |
| 20215219 | 20155507 | 1.75 | 51 | Curative (C) | 2019-08-01 | 2019-08-22 | Sorafenib | 02 | Y | SORAFENIB | 101426116 |
| 20215224 | 20155508 | 1.72 | 93.5 | Palliative (P) | 2016-12-28 | 2018-01-08 | GO2 TRIAL | 99 | N | TRIAL | 100969979 |
| 20215229 | 20155509 | 1.67 | 95.1 | Palliative (P) | null | 2021-11-27 | Capecitabine 35days + RT | N | N | EOX | 100418435 |
| 20215231 | 20155510 | 1.63 | 61.95 | Palliative (P) | 2018-11-23 | 2018-11-23 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + IRINOTECAN + MDG | 101591861 |
| 20215232 | 20155511 | 1.43 | 64.7 | Palliative (P) | 2017-02-22 | 2017-07-27 | EOX | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101160496 |
| 20215235 | 20155512 | 1.59 | 79 | Adjuvant (A) | 2021-04-20 | 2021-05-15 | EOX | 02 | N | SORAFENIB | 100631339 |
| 20215236 | 20155513 | 1.84 | 55.3 | Palliative (P) | null | 2017-10-26 | CAPECITABINE + RT | N | N | CAPECITABINE + RT | 100010670 |
| 20215238 | 20155514 | 1.73 | 85.4 | null | 2020-06-12 | 2020-06-18 | EOX | N | null | EOX | 101305267 |
| 20215239 | 20155515 | 1.62 | 86.6 | Palliative (P) | 2019-02-13 | 2019-02-27 | Trial Unspecified | 02 | N | OXALIPLATIN + RALTITREXED | 100518325 |
| 20215244 | 20155516 | 1.6 | null | Palliative (P) | 2017-09-09 | 2017-10-17 | Trial Unspecified | 2 | N | TRIAL | 101767037 |
| 20215260 | 20155517 | 1.69 | 79.2 | Palliative (P) | 2017-09-11 | 2017-09-11 | IRINOTECAN + MDG + PANITUMUMAB | 99 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101816024 |
| 20215262 | 20155518 | 1.82 | 102 | Palliative (P) | 2020-02-01 | 2020-02-02 | Capecitabine 35days + RT | N | N | EOX | 100027391 |
| 20215265 | 20155519 | 1.57 | 59.2 | Neo-adjuvant (N) | null | 2017-09-11 | EOX | 2 | N | TRIAL | 100272429 |
| 20215266 | 20155520 | null | 79.4 | Palliative (P) | 2019-08-28 | 2019-12-28 | EOX | 02 | N | SORAFENIB | 100084391 |
| 20215271 | 20155521 | 1.75 | 73.3 | Adjuvant (A) | 2020-02-01 | 2020-02-22 | CETUXIMAB + OXALIPLATIN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100286930 |
| 20215274 | 20155522 | 1.66 | 79.7 | Palliative (P) | 2019-04-04 | 2019-04-04 | EOX | 99 | null | CETUXIMAB + IRINOTECAN + MDG | 101146999 |
| 20215276 | 20155523 | 1.78 | 135 | null | 2017-02-27 | 2017-02-27 | EOX | N | null | OXALIPLATIN + RALTITREXED | 101214701 |
| 20215278 | 20155524 | 1.78 | 66.9 | Adjuvant (A) | 2021-11-18 | 2021-12-14 | EOX | 02 | N | OXALIPLATIN + RALTITREXED | 100168435 |
| 20215280 | 20155525 | 1.66 | 64.8 | null | 2020-09-29 | 2020-10-09 | Trial Unspecified | 02 | null | TRIAL | 100568913 |
| 20215281 | 20155526 | 1.63 | 59.3 | null | 2016-12-16 | 2017-02-24 | FLUOROURACIL + IRINOTECAN + Panitumumab | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100433127 |
| 20215292 | 20155527 | 1.44 | 80 | Curative (C) | 2019-01-24 | 2019-02-02 | IRINOTECAN + MDG + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100837498 |
| 20215294 | 20155528 | 1.62 | 71.9 | Neo-adjuvant (N) | 2020-11-10 | 2020-12-01 | Cetuximab + Oxaliplatin + MdG Maint | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101140458 |
| 20215296 | 20155529 | 1.72 | 53.6 | null | 2016-11-30 | 2016-12-28 | Sorafenib | 02 | Y | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100967309 |
| 20215298 | 20155530 | 1.72 | 81.1 | Palliative (P) | 2016-09-24 | 2016-12-23 | Sorafenib | 02 | N | SORAFENIB | 100437023 |
| 20215306 | 20155531 | 1.71 | 53.9 | Palliative (P) | 2019-07-20 | 2019-07-20 | Trial Unspecified | N | N | TRIAL | 100856600 |
| 20215317 | 20155532 | 1.63 | 74 | Adjuvant (A) | 2020-09-07 | 2020-09-07 | IRINOTECAN + MDG + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100633123 |
| 20215318 | 20155533 | 1.72 | 60.4 | null | 2017-05-06 | 2017-06-01 | Capecitabine 35days + RT | 99 | null | CETUXIMAB + IRINOTECAN + MDG | 101365667 |
| 20215319 | 20155534 | 1.65 | 59 | Palliative (P) | 2016-04-15 | 2016-05-02 | CETUXIMAB + OXALIPLATIN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100558155 |
| 20215327 | 20155535 | 1.66 | 66.3 | null | 2020-06-04 | 2020-10-10 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 100229588 |
| 20215328 | 20155536 | 1.74 | 87 | Neo-adjuvant (N) | 2019-06-04 | 2019-06-04 | EOX | 02 | N | OXALIPLATIN + RALTITREXED | 100874783 |
| 20215329 | 20155537 | 1.72 | 71.2 | Palliative (P) | 2018-12-12 | 2019-01-17 | EOX | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101630768 |
| 20215335 | 20155538 | 1.71 | 92.7 | Neo-adjuvant (N) | 2019-08-02 | 2019-08-17 | Capecitabine 5days + RT | 02 | N | CAPECITABINE + RT | 101038282 |
| 20215340 | 20155539 | 1.74 | 93 | Palliative (P) | 2019-11-06 | 2019-11-27 | CAPECITABINE + RT | 02 | N | CAPECITABINE + RT | 101486981 |
| 20215343 | 20155540 | 1.59 | 70 | null | 2017-12-07 | 2017-12-08 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | OXALIPLATIN + RALTITREXED | 101695982 |
| 20215348 | 20155541 | 1.86 | 48.5 | Palliative (P) | 2020-03-10 | 2020-03-17 | Trial Unspecified | 02 | N | TRIAL | 101836126 |
| 20215349 | 20155542 | 1.84 | 53 | 03 | 2019-01-08 | 2019-01-30 | EOX | 02 | null | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101565501 |
| 20215358 | 20155543 | 1.67 | 71.9 | Palliative (P) | 2019-08-02 | 2019-08-19 | Cetuximab + FLUOROURACIL + OXALIPLATIN | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101339318 |
| 20215359 | 20155544 | 1.64 | 89.3 | Curative (C) | 2020-11-24 | 2020-11-27 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 100609920 |
| 20215361 | 20155545 | 1.63 | null | Palliative (P) | 2019-05-18 | 2019-09-17 | IRINOTECAN + MDG + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100729202 |
| 20215363 | 20155546 | 1.79 | 76 | Adjuvant (A) | 2019-08-08 | 2020-07-30 | CAPECITABINE + RT | 02 | N | CAPECITABINE + RT | 100193452 |
| 20215365 | 20155547 | 1.76 | 59 | Palliative (P) | 2016-10-06 | 2016-10-22 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 101375192 |
| 20215366 | 20155548 | 1.67 | 96 | Palliative (P) | null | 2019-04-17 | Trial Unspecified | 02 | null | CAPECITABINE + RT | 101777888 |
| 20215371 | 20155549 | 1.72 | 107 | Palliative (P) | 2019-08-18 | 2019-09-02 | Trial Unspecified | 01 | N | TRIAL | 101781786 |
| 20215372 | 20155550 | 1.54 | 76.4 | Palliative (P) | 2018-12-24 | 2019-04-02 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + IRINOTECAN + MDG | 101201343 |
| 20215375 | 20155551 | 1.88 | 87.8 | Palliative (P) | 2018-05-14 | 2018-05-29 | Sorafenib | 02 | N | SORAFENIB | 101043799 |
| 20215380 | 20155552 | 1.6 | 93.2 | Palliative (P) | 2017-07-26 | 2018-07-23 | EOX | 01 | N | CETUXIMAB + IRINOTECAN + MDG | 101051056 |